About the Summit
The annual Coverage for SCD Summit provides a collaborative forum to discuss the changing landscape of healthcare coverage for sickle cell disease (SCD). This meeting brings together payers, providers, pharmaceutical manufacturers, patient groups, researchers, care teams, and policymakers to discuss ways to tackle the complexities of coverage and access to SCD treatments and care.
This year’s event will feature sessions on:
- Innovative Access Models for Sickle Cell Disease: Learn about the CMS Cell and Gene Therapy Access Model and how it aims to expand access to cutting-edge treatments for Sickle Cell Disease (SCD), ensuring equitable care delivery.
- Medicaid Access and Coverage Insights: Hear from healthcare experts and state Medicaid directors about the current landscape of Medicaid coverage for SCD, key challenges, and actionable policy recommendations to improve access and reduce disparities.
- State-Level Strategies for Gene Therapy Adoption: Discover how states are navigating the integration of cell and gene therapies into Medicaid programs, with a focus on overcoming barriers to access and enhancing health outcomes for SCD patients.
- Patient Experiences and Community Engagement: Gain valuable insights from patients who have accessed new therapies for SCD, along with discussions on how community-based organizations (CBOs) are addressing critical healthcare coverage gaps for underserved populations.
- …and more!
Who Should Attend?
